On September 10, 2019 The New York Proton Center (NYPC) reported that has treated its first proton therapy cancer patients (Press release, Varian Medical Systems, SEP 10, 2019, View Source [SID1234539405]). Equipped with the Varian ProBeam proton therapy system, NYPC is New York State’s first proton therapy facility and is a collaboration between Memorial Sloan Kettering Cancer Center, Montefiore Health System, and Mount Sinai Health System .
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
NYPC is expected to treat 1,400 patients annually, including most children in New York City with solid tumors, delivering the most advanced form of cancer radiation treatment currently available. Before NYPC was opened, proton therapy patients in the New York Metro area were referred to out-of-state facilities.
"We are thrilled to be delivering the highest standard of treatment possible and ensuring our patients – many of them children – are receiving this advanced oncology therapy without having to travel out of the state," said Dr. Charles B. Simone,II, FACRO, chief medical officer at the New York Proton Center. "With the state-of-the-art Varian ProBeam system, we know that our experienced team of proton therapy experts are able to provide patients with the most advanced radiation treatment modality possible."
Proton therapy uses protons, accelerated to about two-thirds the speed of light, or more than 100,000 miles per second, to destroy cancer cells, while minimizing exposure to nearby healthy tissues. NYPC will treat pediatric and adult patients with a wide variety of conditions, including brain and spine tumors, head and neck tumors, breast cancer, lung and other thoracic cancers, gastrointestinal cancers, sarcomas, gynecologic cancers, prostate cancer, lymphomas and recurrence cancers.
"Seeing our collaboration with long-term strategic partners in radiation oncology at New York Proton Center come to fruition is a very proud moment for Varian," said Kolleen Kennedy, president, Proton Solutions and chief growth officer at Varian. "This means the most advanced cancer care for patients in the greater New York area, and we are excited to build upon this strong foundation as we partner to deliver on the promise of a world without fear of cancer."